PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2001 | 3 | 29-36
Article title

The renaissance of antibody

Title variants
Languages of publication
PL
Abstracts
EN
The ability of human and animal immunological system to generate many hundreds of millions of antibodies with different variable-region domains allows to bind other proteins, peptides and low molecular weight haptens despite the enormous variety of chemical and physical structures that these entities can represent. The prediction of Paul Ehrlich in 1900 an age of 'magic bullet applications in human therapeutics is now being realized. Hybrydoma technology introduced in 1975 was crucial event for immunology and biotechnology, providing large amounts of specific monoclonal antibodies (Mab) for basic research, immunodiagnosis, serotherapy and industrial processes. During last 20 years significant progress has been made in production of Mab or Mab fragments by DNA recombination techniques and expression in bacteria, yeast, mammalian cells and transgenic animals and plants. The rapid isolation of high affinity human Mab from phage display libraries and by immunization of transgenic mice will facilitate the development of therapeutic antibodies. It become also clear that antibodies and antibody fragments are playing increasing contribution not only to pharmaceutical but also to food, cosmetic and chemical industries, as well as to environmental protection.
Keywords
Publisher

Journal
Year
Issue
3
Pages
29-36
Physical description
Contributors
References
Document Type
REVIEW
Publication order reference
E. Walajtys-Rode, Instytut Biologii i Ochrony Srodowiska, Wyzsza Szkola Pedagogiczna, ul. Cegielniana 12, 35-310 Rzeszow, Poland, e-mail: ewlajty@univ. rzeszow.pl
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-5910c8be-e84e-3a58-9f27-ceb87aef659d
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.